Decoration of fibrinogen γ-chain peptide on adenosine diphosphate-encapsulated liposomes enhances binding of the liposomes to activated platelets

International Journal of Pharmaceutics

Volumn 407, Issue 1-2, 2011, Pages 151-157

  Tokutomi, Koji ^a   Tagawa, Toshiaki ^a   Korenaga, Maki ^a   Chiba, Masatoshi ^a   Asai, Tomohiro ^b   Watanabe, Naohide ^c   Takeoka, Shinji ^d   Handa, Makoto ^c   Ikeda, Yasuo ^d   Oku, Naoto ^b  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d WASEDA UNIVERSITY   (Japan)

Author keywords

ADP; Fibrinogen; Hemostasis; Liposome; Platelet aggregation

Indexed keywords

ADENOSINE DIPHOSPHATE; FIBRINOGEN; FIBRINOGEN RECEPTOR; HISTIDYLHISTIDYLLEUCYLGLYCYLGLYCYLALANYLLYSYLGLUTAMINYLALANYLGLYCYLASPARTYLVALINE; LIPOSOME; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; ENCAPSULATION; HEMOSTASIS; HUMAN; HUMAN CELL; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; BLOOD PLATELETS; FIBRINOGEN; HEMOSTASIS; HUMANS; INHIBITORY CONCENTRATION 50; LIPOSOMES; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN BINDING;

EID: 79952312081     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.01.014     Document Type: Article

References (25)

1. Agam, G., Livine, A.A., 1992. Erythrocytes with covalently bound fibrinogen as a cellular replacement for the treatment of thrombocytopenia. Eur. J. Clin. Invest. 22, 105-112.
2. Andrieux, A., Hudry-Clergeon, G., Ryckewaert, J.J., Chapel, A., Ginsberg, M.H., Plow, E.F., Marguerie, G., 1989. Amino acid sequences in fibrinogen mediating its interaction with its platelet receptor, GPIIb/IIIa. J. Biol. Chem. 264, 65-9258.
3. Blajchman, M.A., 2003. Substitutes and alternatives to platelet transfusions in thrombocytopenic patients. J. Thromb. Haemost. 1, 1637-1641.
4. Casals, E., Verdaguer, A., Tonda, R., Galan, A., Escolar, G., Estelrich, J., 2003. Atomic force microscopy of liposomes bearing fibrinogen. Bioconjug. Chem. 14, 593-600.
5. Coller, B.S., Springer, K.T., Beer, J.H., Mohandas, N., Scudder, L.E., Norton, K.J., West, S.M., 1992. Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusion. J. Clin. Invest. 89, 546-555.
6. Du, X., Plow, E.F., Frelinger III, A.L., O'Toole, T.E., Loftus, J.C., Ginsbeg, M.H., 1991. Ligands "activate" integrin αIIbβ3 (platelet GPIIb-IIIa). Cell 65, 409-416.
7. Gartner, T.K., Bennett, J.S., 1985. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J. Biol. Chem. 260, 11891-11894.
8. Graham, S.S., Gonchoroff, N.J., Miller, J.L., 2001. Infusible platelet membranes retain partial functionality of the platelet GPIb/IX/V receptor complex. Am. J. Clin. Phathol. 115, 144-147.
9. Halle, M., Berg, A., Keul, J., Baumstark, M.W., 1996. Association between serum fibrinogen concentrations and HDL and LDL subfraction phenotypes in healthy men. Arterioscler. Thromb. Vasc. Biol. 16, 144-148.
10. Kloczewiak, M., Timmons, S., Lukas, T.J., Hawiger, J., 1984. Platel receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the gamma chain. Biochem. 23, 1767-1774.
11. Kuwahara, M., Sugimoto, M., Tsuji, S., Matsui, H., Mizuno, T., Miyata, S., Yoshioka, A., 2002. Platelet shape changes and adhesion under high shear flow. Arterioscler. Thromb. Vasc. Biol. 22, 329-334.
12. Levi, M., Friedrich, P.W., Middleton, S., De Groot, P.G., Wu, Y.P., Harris, R., Biemond, B.J., Heijien, F.G., Levin, J., Ten Cate, J.W., 1999. Fibrinogen-coated albumin microcapsules reduce bleeding in severely replacement for the treatment of thrombocytopenic rabbits. Nat. Med. 5, 107-111.
13. Michael, W.M., 1990. Fibrin polymerization and its regulatory role in hemostasis. J. Lab. Clin. Med. 116, 8-17.
14. Michael, W.M., 1992. The roles of fibrinogen and fibrin in hemostasis and thrombosis. Semin. Hematol. 29, 177-188.
15. Milton, J.G., Hutton, R.A., Tuddenham, E.G., Frojmovic, M.M., 1985. Platelet size and shape in hereditary giant platelet syndromes on blood smear and in suspension: evidence for two types of abnormalities. J. Lab. Clin. Med. 106, 326-335.
16. Okamura, Y., Takeoka, S., Teramura, Y., Maruyama, H., Tsuchida, E., Handa, M., Ikeda, Y., 2005a. Hemostatic effects of fibrinogen γ-chain dodecapeptide-conjugated polymerized albumin particles in vitro and in vivo. Transfusion 45, 1221-1228. (Pubitemid 40935024)
17. Okamura, Y., Maekawa, I., Teramura, Y., Maruyama, H., Handa, M., Ikeda, Y., Takeoka, S., 2005b. Hemostatic effects of phospholipid vesicles carrying fibrinogen γ chain dodecapeptide in vitro and in vivo. Bioconjug. Chem. 16, 1589-1596.
18. Okamura, Y., Fujie, T., Maruyama, H., Handa, M., Ikeda, Y., Takeoka, S., 2007. Prolonged hemostatic ability of poly(ethylene glycol)-modified polymerized albumin particles carrying fibrinogen γ-chain dodecapeptide. Transfusion 47, 1254-1262. (Pubitemid 46934318)
19. Okamura, Y., Takeoka, S., Eto, K., Maekawa, I., Murayama, H., Ikeda, Y., Handa, M., 2009. Development of fibrinogen γ-chain peptide-coated, adenosine diphosphate-encapsulated liposomes as a synthetic platelet substitute. J. Thromb. Haemost. 7, 470-477.
20. Plow, E.F., Pierschbacher, M.D., Ruoslahti, E., Marguerie, G., Ginsberg, M.H., 1985. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc. Natl. Acad. Sci. U.S.A. 82, 8057-8061.
21. Ruggeri, Z.M., Houghten, R.A., Russell, S.R., Zimmerman, T.S., 1986. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets. Proc. Natl. Acad. Sci. U.S.A. 83, 5708-5712.
22. Ruoslahti, E., 1996. RGD and other recognition sequences for integrins. Annu. Rev. Cell Dev. Biol. 12, 697-715.
23. Rybak, M., Renzulli, L.A., 1993. A liposome based platelet substitutes, the plateletsome, with hemostatic efficacy. Biomater. Artif. Cells Immobil. Biotechnol. 21, 108-118.
24. Takagi, J., Petre, B.M., Walz, T., Springer, T.A., 2002. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 110, 599-611.
25. Timmons, S., Kloczewiak, M., Hawiger, J., 1984. ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets. Proc. Natl. Acad. Sci. U.S.A. 81, 4935-4939.